Novel Therapeutic Targets Identified For Pulmonary Fibrosis

A newly published study of patients with pulmonary fibrosis has discovered multiple genetic variations that should help with future efforts to treat the disease. Pulmonary fibrosis is a condition where lung tissue becomes thickened, stiff and scarred. Currently in the United States, there are no drugs approved for use in cases of the condition's most common and severe form, which is known as idiopathic pulmonary fibrosis (IPF) because the cause of the disease is not known...

Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/VgowvTXNdUk/259178.php

auto sport medical